In a retrospective clinical study on over 300 limited- and extensive-stage patients, elevated LDH levels were associated with significantly lower survival in SCLC [66], whereas citrate synthase has cancer-type-specific roles: depending on the tumor’s metabolic profile, it can inhibit or promote tumor progression [67]. This evidence concerns the gene CS and neoplasm.